[go: up one dir, main page]

WO2009118717A1 - Insufflation de cavités corporelles - Google Patents

Insufflation de cavités corporelles Download PDF

Info

Publication number
WO2009118717A1
WO2009118717A1 PCT/IE2009/000010 IE2009000010W WO2009118717A1 WO 2009118717 A1 WO2009118717 A1 WO 2009118717A1 IE 2009000010 W IE2009000010 W IE 2009000010W WO 2009118717 A1 WO2009118717 A1 WO 2009118717A1
Authority
WO
WIPO (PCT)
Prior art keywords
fluid
aerosol
aerosol generator
insufflation gas
controller
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IE2009/000010
Other languages
English (en)
Inventor
John Power
Niall Smith
Conor Duffy
Keith Gibbons
Pierre Auguste Diemunsch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stamford Devices Ltd
Original Assignee
Stamford Devices Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IE20080238A external-priority patent/IE20080238A1/en
Application filed by Stamford Devices Ltd filed Critical Stamford Devices Ltd
Priority to EP09723714A priority Critical patent/EP2274034A1/fr
Publication of WO2009118717A1 publication Critical patent/WO2009118717A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M13/00—Insufflators for therapeutic or disinfectant purposes, i.e. devices for blowing a gas, powder or vapour into the body
    • A61M13/003—Blowing gases other than for carrying powders, e.g. for inflating, dilating or rinsing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/005—Sprayers or atomisers specially adapted for therapeutic purposes using ultrasonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A61M15/0066—Inhalators with dosage or measuring devices with means for varying the dose size
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/08—Bellows; Connecting tubes ; Water traps; Patient circuits
    • A61M16/0816—Joints or connectors
    • A61M16/0833—T- or Y-type connectors, e.g. Y-piece
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A61M16/14—Preparation of respiratory gases or vapours by mixing different fluids, one of them being in a liquid phase
    • A61M16/16—Devices to humidify the respiration air
    • A61M16/161—Devices to humidify the respiration air with means for measuring the humidity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/75—General characteristics of the apparatus with filters
    • A61M2205/7518—General characteristics of the apparatus with filters bacterial
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B12/00—Arrangements for controlling delivery; Arrangements for controlling the spray area
    • B05B12/08—Arrangements for controlling delivery; Arrangements for controlling the spray area responsive to condition of liquid or other fluent material to be discharged, of ambient medium or of target ; responsive to condition of spray devices or of supply means, e.g. pipes, pumps or their drive means
    • B05B12/081—Arrangements for controlling delivery; Arrangements for controlling the spray area responsive to condition of liquid or other fluent material to be discharged, of ambient medium or of target ; responsive to condition of spray devices or of supply means, e.g. pipes, pumps or their drive means responsive to the weight of a reservoir or container for liquid or other fluent material; responsive to level or volume of liquid or other fluent material in a reservoir or container
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B17/00—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups
    • B05B17/04—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods
    • B05B17/06—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations
    • B05B17/0607—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations generated by electrical means, e.g. piezoelectric transducers
    • B05B17/0638—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations generated by electrical means, e.g. piezoelectric transducers spray being produced by discharging the liquid or other fluent material through a plate comprising a plurality of orifices
    • B05B17/0646—Vibrating plates, i.e. plates being directly subjected to the vibrations, e.g. having a piezoelectric transducer attached thereto
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B17/00—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups
    • B05B17/04—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods
    • B05B17/06—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations
    • B05B17/0607—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations generated by electrical means, e.g. piezoelectric transducers
    • B05B17/0653—Details
    • B05B17/0669—Excitation frequencies

Definitions

  • Laparoscopic surgery also called minimally or less invasive surgery (MIS or Lf S) or keyhole surgery is a modern surgical technique in which operations, in- the body are performed through small incisions as compared to the larger incisions needed in traditional surgical procedures.
  • Gas such as carbon dioxide is delivered, via an. insufflator, into a body cavity such as the abdomen leading to the formation of a pneumoperitoneum, thereby providing sufficient space for the surgeon to operate.
  • the insufflator maintains the pneumoperitoneum and acts to renew the gas when ⁇ leaks occur.
  • HME heat moisture exchangers
  • This invention is directed towards providing a method and an apparatus that will address at least some of these problems.
  • an apparatus for use in laparoscopic surgery comprising: . ,
  • an insufflator for generating an insufflation gas
  • an aerosol generator for aerosolising a fluid and entraining the aerosol with the insufflation gas
  • the aerosol generator comprises a vibratable member having a plurality of apertures extending between a first surface and a second surface
  • a controller to control the operation of the aerosol generator.
  • the controller may be configured to control the flow rate of the fluid to be aerosolised.
  • the controller is configured to deliver different flow rates of aerosol at different stages of a surgical procedure.
  • the controller may be configured to deliver full flow at the start and/or end of a procedure.
  • the controller may be configured to deliver reduced flow during a procedure.
  • the controller is set to deliver a pre-set amount of aerosol into insufflation gas.
  • the apparatus may comprise means for varying the pre-set. amount of aerosol.
  • the means for varying the pre-set amount of aerosol may comprise a user interface such as a key pad or switch.
  • controller is configured to control operation of the aerosol generator responsive to the insufflation gas.
  • the controller may be configured to control operation of the aerosol generator responsive to the flow rate of the insufflation gas.
  • the apparatus comprises a device to determine the fluid flow rate of the insufflation gas.
  • the determining device may comprise a flow sensor such as a flowmeter. Alternatively a differential pressure sensor may be used.
  • a humidity meter is included in the circuit, preferably close to the patient to measure the level of humidification of the gas entering the body.
  • a feedback loop to the controller may be provided to control output from the nebulizer so as to ensure sufficient humidity is present in the insufflation gas.
  • Such a system can be used to provide real time measurement to adjust the output
  • the first surface of the vibratable member is adapted to receive the fluid to be aerosolised.
  • the aerosol generator is configured to generate an aerosol at the second surface of the vibratable member.
  • the vibratable member is dome-shaped in geometry. Alternatively it may be of stretched Hat shape.
  • the vibratable member comprises a piezoelectric element.
  • the apertures in the vibratable member are sized to aerosolise the first fluid by ejecting droplets of the first fluid such that the majority of the droplets by mass have a size of less than 5 micrometers.
  • the apertures in the vibratable member may be sized to aerosolise the first fluid by ejecting droplets of the first fluid such that the majority of the droplets by mass have a size of less than 3. micrometers.
  • the apertures in the vibratable member may be sized to aerosolise the first fluid by ejecting droplets of the first fluid such that the majority of the droplets by mass have a size in a particular pre determined range of less than 10 micrometers.
  • the range may be in a band of 1 to 3 microns and also a different range band of for example 7 — 9 microns.
  • the controller is configured to control the pulse rate at a set frequency of vibration of the vibratable member.
  • the controller may be impedance matched to the aerosol generator.
  • the apparatus comprises means to determine whether the fluid is in contact with the aerosol generator.
  • the determining means may be configured to determine at least one electrical characteristic of the aerosol generator.
  • the determining means may be configured to determine at least one electrical characteristic of the aerosol generator over a range of vibration frequencies. Jn one case the determining means is configured to compare the at least one electrical characteristic against a pre-def ⁇ ned set -of data.
  • the invention also provides a method for carrying out a procedure involving insufflation comprising the steps of:-
  • aerosolising a fluid using an aerosol generator wherein the aerosol generator comprises a vibratable member having a " plurality of apertures extending between a first surface and a second surface: and
  • the method may comprise the step of controlling the aerosolisation of the fluid.
  • the method may comprise controlling the How rate of the fluid.
  • the method comprises delivering different flow rates of 5 aerosol at different stages of a surgical procedure.
  • the method may comprise delivering full flow at the start and/or end of a procedure.
  • the method may comprise delivering reduced flow during a procedure.
  • the method comprises delivering a pre-set amount of aerosol 10 into insufflation gas.
  • the method may comprise the step of varying the pre-set amount.
  • An interface may be operated to vary the pre-set amount.
  • the method comprises controlling aerosolisation of the fluid responsive to the insufflation gas so as to ensure adequate humidification of the 15 insufflation gas.
  • the amount of water a gas can hold is known. Consequently, nebulizer output when linked to insufflator flow can be used to provide sufficient aerosol to humidify the gas.
  • a humidity meter is included in the circuit, preferably close to the 20 patient to measure the level of humidification of the gas entering the body.
  • a feedback loop to the controller may be provided to control output from the nebulizer so as to ensure sufficient humidity is present in the insufflation gas.
  • Such a system can be used to provide real time measurement to adjust the output from the nebulizer.
  • the method comprises controlling aerosolisation of the fluid responsive to the flow rate of the insufflation gas. In one embodiment the method comprises the step of determining the flow rate of the insufflation gas.
  • the method comprises the step of determining if the fluid is in contact with an aerosol generator. This may involve determining at least one electrical characteristic of the aerosol generator. Electrical characteristics of the aerosol generator may be determined over a range of vibration frequencies. .
  • the method comprises the step of comparing the at least one electrical characteristic against a pre-defined set of data.
  • the method comprises the step of delivering the entrained fluid and insufflation gas into a body to insufflate at least part of the body.
  • the fluid is an aqueous solution.
  • the aqueous solution may be saline having a salt concentration >l ⁇ M
  • the fluid contains a therapeutic and/or prophylactic agent.
  • the agent may be one or more selected from the group comprising an analgesic, an anti-inflammatory, an anti-infective, an anaesthetic, an anti-cancer chemotherapy agent, and/or anti-adhesion agent.
  • the procedure is a laparoscopic procedure.
  • FIG. 1 is a perspective view of an apparatus according to the invention for use in a procedure involving insufflation of a body cavity, such as laparoscopic surgery;
  • Fig. 2 is a schematic illustration of a part of an apparatus according to the 10 invention.
  • FIG. 3 is a schematic illustration of a part of the apparatus of Fig. 1 :
  • Fig. 4 is an exploded isometric view of an aerosol generator used in the 15 . invention.
  • Fig. 5 is a cross-sectional view of the assembled aerosol generator of Fig. 4;
  • Fig. 6 is a perspective view of a controller housing used in the apparatus of the invention.
  • Figs. 7(a) and 7(b) are graphs of DC voltage versus time and AC voltage versus time respectively to achieve a 100% aerosol output; 25
  • Figs. 8 ⁇ a) and 8(b) are graphs of DC voltage versus time and ⁇ C voltage versus time respectively to achieve a 50% aerosol output -
  • Fig 8(a) illustrates the waveform output from a microprocessor to a drive.
  • circuit and Fig 8(b) illustrates the waveform output from a drive circuit to a nebuliser;
  • Figs. 9(a) and 9(b) are graphs of DC voltage versus time and AC voltage • ' ⁇ • versus. time ⁇ respectively to achieve a 25% aerosol output -
  • Fig 9(a) illustrates the waveform output from a microprocessor to a drive circuit and
  • Fig 9(b) illustrates the waveform output from a drive circuit to a nebuliser;
  • Fig 10 is a graph of AC voltage versus time; and illustrates an output waveform from a drive circuit to a nebuliser;
  • Fig. 1 1 is a graph of frequency versus current for another apparatus according to the invention.
  • Fig. 12 is a view similar to Fig. 1 of another apparatus of the invention:
  • Fig. 13 is a view similar to Fig. 1 of a further apparatus of the invention.
  • Fig. 14 is a view similar to Fig. 1 of a still further apparatus of the invention.
  • Fig. 15 is a view similar to Fig. 1 of another apparatus of the invention.
  • Fig. 16 is a view similar to Fig. 1 of a further apparatus of the invention.
  • Fig. 17 is a partially cross sectional view of a detail of the. apparatus of Fig. 16; - Fig. 18 is a view similar to Fig. 1 of another apparatus of the invention.
  • Fig. 19 is an enlarged view of a detail of the apparatus of Fig. 18.
  • FIG. 1 there is illustrated an apparatus according to the invention for use in insufflation of a body cavity.
  • One such application is laparoscopic surgery.
  • the device is also suitable for use in any situation involving insufflation of a body cavity such as in arthroscopies, pleural cavity insufflation (for example during thoracoscopy), retroperitoneal insufflations (for example retroperitoneoscopy), during hernia repair, during mediastinoscopy and any other such procedure involving insufflation.
  • the apparatus comprises a reservoir 1 for storing an aqueous solution, an aerosol generator 2 for aerosolising the solution, and a controller 3 for controlling operation of the aerosol generator 2.
  • the aqueous solution is fed from a reservoir 9 to the aerosol generator 2 along a delivery tube 13.
  • aerosolised aqueous solution is entrained with insufflation gas.
  • the gas is any suitable insufflation gas such as carbon dioxide.
  • suitable insufflation gases are nitrogen, helium and xenon.
  • the insufflation gas is delivered into an insufflation gas tubing 15 by an insufflator 12.
  • the insufflator 12 may be of any suitable type such as those available from Karl Storz, Olympus and Stryker.
  • the insufflator 12 has an outlet 20 through which insufflation gas is delivered.
  • a bacterial filter 21 may be provided within the insufflator or. as illustrated, downstream of the insufflator outlet 20.
  • a flow rate sensor/meter 1 1 is located in the flow path of the insufflation gas from an insufflator 12 to the aerosol generator 2.
  • the flow rate sensor/meter 1 1 is connected by a control wire 70 to the controller 3. and the aerosol generator 2 is connected to the controller 3 by a control wire 16.
  • the flow rate sensor/meter 1 1 may be a hot wire anemometer, or in the case where the flow is laminar or can be laminarised, a differential pressure transducer.
  • Sterile water may be used.
  • any suitable solution may be used.
  • Solutions- with a salt concentration in the range l ⁇ M (micro molar) to 154mM (mllli molar) (0.9% saline) are optimum as they cover the majority of medical applications.
  • saline concentrations can be readily nebulised using the aerosolisation technology used in the invention.
  • Liquid, saline or water for humidifying purposes only and/or medicament can be delivered into the nebulizer reservoir through the opening in the top of the nebulizer that is appropriately sized to receive standard nebules or alternatively may be applied by syringe or other delivery means.
  • Aqueous solution may be stored in the reservoir 1 container of the nebuliser or the aqueous solution may be delivered to the reservoir 1 of the aerosol generator 2 in this case from the supply reservoir 9 along the delivery line 13.
  • the flow of aqueous solution may be by gravity and/or may be assisted by an in-line flow controlling device 17 such as a pump and/or a valve which may be positioned in the delivery line 13.
  • the operation of the flow controlling device 17 may be controlled by the controller 3 along a control wire 18 to ensure that the aerosol generator 2 has a supply of aqueous solution during operation.
  • the device 17 may be of any suitable type.
  • the apparatus comprises a connector 30, in this case a T--piece connector 30 having an insufflation gas conduit inlet 31 and an outlet 32.
  • the connector 30 also comprises an aerosol supply conduit 34 for delivering the aerosol from the aerosol generator 2 into the insufflation gas conduit 15 to entrain the aerosol with the insufflation gas, passing through the gas insufflation conduit 15.
  • the entrained aerosol/insufflation gas mixture passes out of the connector 30 through the outlet 32 and is delivered to the body cavity along a line 60.
  • the aerosol supply conduit 34 and the insufflation gas conduit meet at a junction.
  • the aerosoi supply conduit of the connector 30 may be releasably mounted to. a neck 36 of the aerosol generator housing by means of a push-fit arrangement. This enables the connector 30 to be easily dismounted from the aerosol generator housing 36. for example for cleaning.
  • the neck 36 at least partially lines the interior of the aerosol supply conduit 34.
  • the nebuliser (or aerosol generator), has a vibratable member which is vibrated at ultrasonic frequencies to produce liquid droplets.
  • Some specific, non-limiting examples of technologies for producing fine liquid droplets is by supplying liquid to an aperture plate having a plurality of tapered apertures, extending between a first surface and a second surface thereof and vibrating the aperture plate to eject liquid droplets through the apertures. Such technologies are described generally in U.S. Pat. Nos. 5,164.740; 5,938,117; 5,586,550; 5,758,637: 6,014/970,
  • the liquid to be aerosolised is received at the first surface, and the aerosol generator 2 generates the aerosolised first fluid at the second surface by. ejecting droplets of the first fluid upon vibration of the vibratable member.
  • the apertures ⁇ in the vibratable member are sized to aerosolise the liquid by ejecting droplets of the liquid such that the majority of the droplets by mass have a size of less than 5 micrometers.
  • the vibratable member 40 could be non-planar, and may be dome- shaped in geometry.
  • the aerosol generator 2 comprises a vibratable member 40, a piezoelectric element 41 and a washer 42, which are sealed within a silicone overmould 43 and secured- in place within xhe housing 36 using a retaining ring 44.
  • the vibratable member 40 has a plurality of tapered apertures extending between a first surface and a second surface thereof.
  • the first surface of the vibratable member 40 which in use faces upwardly; receives the liquid medicament from the reservoir 1 and the aerosolised - medicament, is generated at the second surface of the vibratable member 40 by . ejecting droplets of medicament upon vibration of the member 40. In use the second surface faces downwardly.
  • the apertures in the vibratable member 40 may be sized to produce an aerosol in which the majority of lhe droplets by weight have a size of less than 5 micrometers.
  • the complete nebuliser may be supplied in sterile form, which is a significant advantage for a surgical device.
  • the controller 3 controls operation of and provides a power supply to the aerosol generator 2.
  • the aerosol generator has a housing which defines the reservoir 1.
  • the housing has a signal interface port 38 fixed to the lower portion of the reservoir 1 to receive a control signal from the controller
  • the controller 3 may be connected to the signal interface port 38 by means of a control lead 39 which has a docking member 50 for mating with the port 38.
  • a control signal and power may be passed from the controller 3 through the lead 39 and the port 38 to the aerosol generator 2 to control the operation of the aerosol generator 2 and to supply power to the aerosol generator 2 respectively.
  • the power source for the controller 3 may be an on-board power source, such as a rechargeable battery, or a remote power source, such as a mains power source, or an insufflator power source.
  • a remote power source such as a mains power source, or an insufflator power source.
  • an AC-DC converter may be connected between the AC power source and the controller 3.
  • a power connection lead may be provided to connect a power socket of the controller 3 with the remote power source.
  • the controller 3 has a housing and a user interface to selectively control operation of the aerosol generator 2.
  • the user interface is provided on the housing which, in use, is located remote from the aerosol generator housing.
  • the user interface may be in the form of, for example, an on-off button.
  • a button can be used to select pre-set values for simplicity of use.
  • a dial mechanism can be used to select from a range of values from 0-100%.
  • Status indication means are also provided on the housing to indicate the operational state of the aerosol generator 2.
  • the status indication means may be in the form of two visible LED's. with one LED being used t ⁇ indicate power and the other LED being used to indicate aerosol delivery. Alternatively one LED may be used to indicate an operational state of the aerosol generator 2. and the other LED may be used to indicate a rest state of the aerosol generator. 2.
  • a fault indicator may also be provided in the form of an LED on the housing.
  • a battery charge indicator in the form of an LED may be provided at the side of the housing.
  • the aqueous solution in the reservoir 9 flows by gravitational action towards the aerosol generator 2 at the lower medicament outlet.
  • the controller 3 may then be activated to supply power and a control signal to the aerosol generator 2, which causes the piezoelectric element 41 to vibrate the non-planar member 40.
  • This vibration of the non-planar member 40 causes the aqueous solution at the top surface of the member 40 to pass through the apertures to the lower surface where the aqueous solution is aerosolised by the ejection of small droplets of solution.
  • the aerosol passes from the aerosol generator 2 into the neck 36 of the aerosol generator housing, which is mounted within the aerosol supply conduit of the connector 30 and into the gas conduit of the connector 30 (flow A).
  • the aerosol is entrained in the insufflation gas conduit with gas. which passes into the gas conduit through the inlet 31 (flow B).
  • the entrained mixture of the aerosol and the insufflation gas then passes out of the gas conduit through the outlet 32 (flow C) and on via an insufflator line 60 to a patient, for example into the abdomen of the patient.
  • the flow of the insufflation gas into- the abdomen of a patient is commenced to insufflate the abdomen.
  • the ⁇ ow rate sensor/meter 1 1 determines the flow rale of the insufflation gas.
  • the controller 3 commences operation of ⁇ the aerosol generator 2 to aerosolise the aqueous solution. .
  • the aer.osol ⁇ sed aqueous solution is entrained with the insufflation gas, and delivered into the abdomen of the patient to insufflate at least part of the abdomen. ..
  • the flow rate sensor/meter 1 1 determines the alteration, and the controller 3 alters the pulse rate of the vibratable member of the nebulise) accordingly. . , •
  • the controller 3 is in communication with the flow rate sensor/meter I i .
  • the controller 3 is configured to control operation of the aerosol generator. 2, responsive to the fluid flow rate of the insufflation gas and also independent of the fluid flow rate of the insufflation gas as required.
  • the controller 3 is configured to control operation of the aerosol generator 2 by controlling the pulse rate at a set frequency of vibration of the ; vibratable member, and thus controlling the fluid flow rate of the aqueous, solutions.
  • the controller 3 may comprise a microprocessor 4, a boost circuit -5, and a drive circuit 6.
  • Fig. 2 illustrates the microprocessor.4, the boost circuit 5, the drive circuit 6 comprising impedance matching components (inductor), the nebuliser 2, and the aerosol.
  • the inductor impedance is matched to the' impedance of. the piezoelectric element of the aerosol generator 2.
  • the microprocessor 4 generates a square waveform of 128KHz which is sent to the drive circuit 6.
  • the boost circuit 5 generates a 12V DC voltage required by the drive circuit 6 from an input, of either a 4.5V battery or a 9V AC/DC adapter.
  • the circuit is matched to the impedance of the pi ⁇ zo ceramic element tc ensure enhanced energy transfer.
  • the drive frequency may be started and stopped as . required using the microprocessor 4. This allows for control of flow rate by driving the nebuliser 2 for any required pulse rate.
  • the microprocessor 4 may control the on .and off times to an accuracy of milliseconds.
  • the nebuliser 2 may be calibrated at a certain poise rale by measuring how long it. takes to deliver a know quantity of solution. There is. a linear relationship between the pulse rate and the nebuliser flow rate. This allows for accurate control over the delivery rate of the aqueous solution. 0
  • the nebuliser drive circuit consists of the electronic components designed to generate output sine waveform of approximately 100V AC which is fed to nebuliser 2 causing aerosol to be generated.
  • the nebuliser drive circuit 6 uses
  • the aerosol generator 2 may be configured to operate in a variety of different modes, such as continuous, and/or phasic, and/or optimised.
  • Fig 7(a) illustrates a 5V DC square waveform output from the microprocessor 4 to the drive circuit 6.
  • Fig 7(b) shows a low power
  • the aerosol generator may be operated in this mode to achieve 10Q?/o aerosol output.
  • Figs 8(a) in another example, there is illustrated a 5V DC square waveform output from the microprocessor 4 to the drive circuit 6.
  • Fig 8(b) shows a low power, -100V AC sine waveform output from the drive circuit 6 to the nebuliser 2.
  • Both waveforms have a period p of 7.8 ⁇ S giving them a frequency of 1/7.8 ⁇ s which is approximately 128IvHz.
  • the wavefoms are ⁇ chopped (stopped/OFF) for a period of time x. In this case the off time x is-equal to the on time x.
  • the aerosol generator may be operated in this mode to achieve 50% aerosol output.
  • Figs 9(a) there is illustrated a 5V DC square waveform output from microprocessor 4 to drive circuit 6.
  • Fig 9(b) shows a low power, -100V AC sine waveform output from the drive circuit 6 to the nebu ⁇ ser
  • Both waveforms have a period p of 7.8 ⁇ S giving them a frequency of 1/7.8 ⁇ s which is approximately 128KHz. In both cases the wavefoms are chopped
  • the aerosol generator may be operated in this mode to achieve 25% aerosol output.
  • pulsing is achieved by specifying an on- time and. off-time for the vibration of the aperture plate. If the on-time is set to 200 vibrations and off-time is set to 200 vibrations, the pulse rate is 50% (V?. on V 2 off). This means that the flow rale is half of that of a fully driven aperture plate. Any number of vibrations can be specified but to achieve a linear relationship between flow rale >and pulse rate a minimum number of on-time vibrations is • • 5 specified since it takes a finite amount of time for the aperture plate, to. reach .its. maximum amplitude of vibrations. ⁇ . '
  • the drive frequency can be started and stopped as required by the microprocessor; this allows control of flow rate by driving the nebuliser for any required pulse 10 rate.
  • the microprocessor can control the on and off times with an accuracy of microseconds.
  • a nebuliser can be calibrated at a certain pulse rate by measuring how long it takes Io deliver a known quantity of solution. There is a linear relationship
  • 20 flow rates of the two nebulizers are different.
  • one with an inherent output of 0.088mI/m ⁇ n and a second with an inherent output of 0.1-76ml/roin the first nebulizer is controlled with a 50:50 on:off pulse rate, with the second set to. a- 25:75 on-off pulse rate so that both nebulizers give a 0.044ml/m ⁇ n output.
  • the nebulizers when located in the insufflation circuit have the potential to provide exactly the same rate of aerosol output as each' other. This is possible because the amount of humidity a gas can hold is a known constant dependent on controllable factors.
  • the pulse rate may be lowered so that the velocity of the emerging aerosol is much reduced so that impaction rain-out is reduced. . ⁇
  • Detection of when the aperture plate is dry can be achieved ' by using the fact that a dry aperture plate has a well defined resonant frequency. If the drive frequency . is swept from 12OkIIz Io 145kHz and the current is measured then if a minimum current is detected less than a set value, the aperture plate must have gone dry. 1 A wet aperture plate has no resonant frequency.
  • the apparatus of the invention may be configured to determine whether there is any of the first fluid in contact with the aerosol generator 2.
  • determining an electrical characteristic of the aerosol generator 2 for example the current flowing through the aerosol generator 2, over a range of vibration frequencies, and comparing this electrical characteristic against a pre-defined set of data, it is possible to determine whether the aerosol generator 2 has any solution in contact with the aerosol generator 2.
  • - Fig. ⁇ ; 1 1 illustrates a curve 80 of frequency versus current when there is some of . jhe solution in contact with the aerosol generator 2, and illustrates a curve 90 of frequency versus current when there is none of the solution in contact with the aerosol generator 2.
  • Fig. 11 illustrates the wet aperture plate curve 80 and the dry aperture plate curve 90.
  • a pump can be added in line to give fine control of the liquid delivery rate which can be nebulised drip by drip.
  • The. rate would be set so that liquid would not build up in the nebuliser.
  • This system is particularly suitable for constant low dose delivery.
  • Fig. 12 there is illustrated another insufflation apparatus which is similar to the apparatus of Fig. 1 and like parts are arranged the same reference numerals.
  • the controller 3 is integrated into the insufflator 12.
  • the insufflator 12 would have information on the rate of flow that it is producing and using an integrated circuit board may directly communicate with the nebuliser 2. This would eliminate the need for the separate flowmeter 1.1 and the stand-alone controller 3 to be present.-
  • FIG. 13 there is illustrated another insufflation apparatus which is similar to the apparatus of Fig. 1 and like parts are again identified by the same reference numerals.
  • the Insufflation gas flow ' signal is provided directly from the insufflator along a lead 71.
  • One advantage of .this arrangement is. that no separate meter/sensor required. . ⁇ • . • .
  • nebuliser reservoir I has a top opening 100 which is closabie by removable plug 101.
  • Liquid, saline of water, for humidifying purposes and/or medicament is delivered into the nebuliser reservoir through the opening 100.
  • the opening 100 is appropriately sized to receive standard nebules containing liquid to be nebulised.
  • the liquid may be applied b ⁇ syringe or other suitable delivery means. ⁇ . '
  • n ⁇ bu ⁇ ser 1 pre-loaded with -medicament to avoid the requirement to separately add medicament to the system.
  • the apparatus of Fig. 14 is operated in a similar way to the modes of operation described above with reference to Figs. 2 to 1 1.
  • nebuliser reservoir 1 has a top opening 100 and ' a removable plug/lid 101 as described with reference' to Fig.
  • the apparatus is operated as described above with .the liquid .being introduced through the opening 100.
  • the nebuliser may be pre-loaded, with0 medicament. ⁇ ' • . .
  • Fig. i 6 there is illustrated another apparatus of the invention which is similar to that described above with reference to Fig. ) 3 and like parts are assigned the same reference numerals.
  • the nebuliser. reservoir 1 again 5 has a top opening 100 and a removable Hd 101 as described with reference to Fig.
  • Fig.. 17 shows the connection of the controller lead 71 to the control circuit 105 of the insufflator 12.
  • nebuliser reservoir 1 is closed by a Hd 130 and the nebuliser is pre-loaded with medicament/liquid which' avoids. ' the 5 requirement to separately add medicament to the system. > .
  • Humidity may be "generated via the aerosolisation of any aqueous, solution. Relative humidity in the 50-100% range would be optimum.
  • the control module can generate a nebuliser output of any defined relative humidity percentage based on the insufflator flow. These solutions include any aqueous drug solution. Solutions with salt concentrations in the range l ⁇ M — 154mM would be optimum.
  • nebulizei to humidify the insufflation gas prior to entering the body will eliminate the need for the body to humidify the gas once it is inside the body, thereby minimizing body heat loss by internal evaporation.
  • control in nebulizer output allows proportional delivery of the required amount of humidity according to the amount of insufflation gas entering the body.
  • this control of aerosolization rate will prevent overloading of the insufflation gas with aerosol which would obscure the surgeons view.
  • the invention provides a system that can deliver different flow rates at different- stages of The surgical procedure. Examples of such different flow rates include:
  • the controller which controls the operation of the aerosol generator is pre-set to deliver a set amount of aerosol into the insufflation gas.
  • the contToller may be set to deliver an amount of 5% into a flow of 1 litre per minute of insufflation gas to avoid fogging.
  • the controller may be pre-set in the factory to operate in this manner.
  • there may be a user interface such as a switch, or keypad which may be used to change the setting.
  • control responsive to an insufflation gas flow sensor is not essential.
  • the nebulizer can also act to deliver any agent presented in an aqueous drug solution.
  • the system facilitates delivery of, for example, pain-reiief medications, anti-infectiv ⁇ s, anti-inflammatory and/or chemotherapy agents in aerosol form to the body cavity.
  • These therapeutic agents could also act as humidifying substances in their own right. ⁇ - .
  • the nebulised liquid entrained in the insufflation gas may contain any desired therapeutic and/or prophylactic agent.
  • an agent may for example be one or ⁇ more of. an analgesic, an anti-inflammatory, an anaesthetic, an anti-infective such as an antibiotic, an anti-cancer chemotherapy agent, and/or any agent which interferes with processes that result in the adhesion function. ⁇ ; .
  • Typical local anaesthetics are. for example, Ropivacaine, ⁇ Bupivacaine and Lidocaine.
  • Typical anti-infectives include antibiotics such as an aminoglycoside, ,. a tetracycline, a fluroquinolone; anti-microbials such as a cephalosporin: and antifungals.
  • Antiinflammatories may be of the steroidal or. non-steroidal type..
  • Anti-cancer chemotherapy agents may be alkylating agents,, antimetabolites a ⁇ thracycl ⁇ nes, plant alkaloids, topoisomerase inhibitors, nitrosoureas, mitotic inhibitors., monoclonal antibodies, tyrosine kinase inhibitors, hormone therapies including corticosteroids, cancer vaccines, anti-estrogens, aromatase inhibitors, anti-androgens, anti-angiogenic agents and other antiturnour agents.
  • the agent which interferes with the adhesion function may be any of those outlined in WO2005/092264A. the entire contents of which are herein incoiporated by reference.
  • the agent may be a crystalloid, hyaluronic acid, polyehtyleneglycol, Tranilasl (N-(3 ⁇ 4'-dirnethoxycmnamoy! anthranilic acid) or a " Neurokinin ! receptor (NK-IR) agonist, such as Aprepitant
  • Typical analgesics include aspirin, acetaminophen, ibuprofe ⁇ . naproxen, a CoXr-2 inhibitor such as celecoxib, morphine, oxycodone and hydrocodone. ⁇
  • the system of. the invention can be used for precise controlled delivery of drug and/or humidity during insufflation. No heating is required.. Consequently there is no risk of damage to drugs, due to heating
  • the system may. be used to provide precise control over aerosol, output can be exercised by utilising pulse rate control.
  • the system may be used for targeted delivery of a range, of drugs, thereby reducing systemic side effects.
  • the system provides alleviation of postsurgical pain experienced by the patient.
  • the system need not be located in the direct flow path of insufflation gas. In - addition, minimal caregiver intervention during laparoscopic procedure is required.
  • the system is small and compact and allows for integration with an insufflator. ' ⁇
  • the device of the invention can be used throughout the procedure carried out by a surgeon.
  • the device ensures that humidity is actively controlled during the procedure and thus ensures that a surgeon's view is clear as fogging is avoided.
  • the nebuliser output is controlled by pulsing to provide delivery of humidity and/or medicament into the insufflation gas during surgery without causing fogging. • . ⁇
  • the control may be provided either by providing a maximum output limit on the nebuliser or by linking directly to the insufflator flow.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Surgical Instruments (AREA)

Abstract

L'invention porte sur un appareil utilisé lors d'une insufflation qui comprend un insufflateur (12) pour générer un gaz d'insufflation tel que du dioxyde de carbone et un générateur d'aérosol (2) pour rendre aérosol un fluide et entraîner l'aérosol avec le gaz d'insufflation qui est distribué durant une opération chirurgicale. Le générateur d'aérosol (2) comprend un élément pouvant vibrer (40) ayant une pluralité d'ouvertures s'étendant entre une première surface et une seconde surface. Le fluide peut comprendre un agent thérapeutique ou prophylactique. Un dispositif de commande (3) est utilisé pour commander le fonctionnement du générateur d'aérosol (2). Le dispositif de commande (3) commande le fonctionnement du générateur d'aérosol (2) en fonction de l'écoulement du gaz d'insufflation tel que détecté par un détecteur d'écoulement (11). La vitesse d'impulsion à une fréquence établie de vibration de l'élément pouvant vibrer (40) est commandée.
PCT/IE2009/000010 2008-03-28 2009-03-27 Insufflation de cavités corporelles Ceased WO2009118717A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP09723714A EP2274034A1 (fr) 2008-03-28 2009-03-27 Insufflation de cavités corporelles

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IE20080238A IE20080238A1 (en) 2007-03-28 2008-03-28 Insufflation of body cavities
IE2008/0238 2008-03-28
IE2008/0781 2008-09-26
IE20080781 2008-09-26

Publications (1)

Publication Number Publication Date
WO2009118717A1 true WO2009118717A1 (fr) 2009-10-01

Family

ID=40624060

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IE2009/000010 Ceased WO2009118717A1 (fr) 2008-03-28 2009-03-27 Insufflation de cavités corporelles

Country Status (2)

Country Link
EP (1) EP2274034A1 (fr)
WO (1) WO2009118717A1 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2371409A1 (fr) * 2010-03-31 2011-10-05 AeroSurgical Limited Insufflation de cavités corporelles
WO2015010809A1 (fr) * 2013-07-24 2015-01-29 Stamford Devices Limited Commande et surveillance de la fréquence de l'entraînement d'une plaque d'ouverture vibrante de nébuliseur
WO2019038408A1 (fr) 2017-08-25 2019-02-28 Stamford Devices Limited Protection de plaque d'orifice pendant la génération d'aérosol
WO2022263049A1 (fr) * 2021-06-16 2022-12-22 Stamford Devices Limited Système de ventilateur
WO2024039805A1 (fr) * 2022-08-18 2024-02-22 Conmed Corporation Systèmes d'humidification pour procédures chirurgicales
EP4431138A1 (fr) * 2023-03-15 2024-09-18 Feellife Health Inc. Atomiseur et dispositif d'atomisation

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164740A (en) * 1991-04-24 1992-11-17 Yehuda Ivri High frequency printing mechanism
EP0937478A1 (fr) * 1998-02-19 1999-08-25 Microflow Engineering SA Appareil et système pour l'administration de medicament intracavité pendant une chirurgie assistée par vidéo ou autres interventions endoscopiques
WO2002032486A1 (fr) * 2000-10-16 2002-04-25 Fisher & Paykel Healthcare Limited Ameliorations apportees a un dispositif utilise pour humidifier des gaz dans des processus medicaux
US6546927B2 (en) * 2001-03-13 2003-04-15 Aerogen, Inc. Methods and apparatus for controlling piezoelectric vibration
US20040000598A1 (en) * 1991-04-24 2004-01-01 Aerogen, Inc. Method and apparatus for dispensing liquids as an atomized spray
US20050012766A1 (en) * 2003-04-21 2005-01-20 Takakazu Fukano Information communicating member, liquid container having information communicating member and liquid ejecting apparatus
US20050084523A1 (en) * 2003-02-28 2005-04-21 Delex Therapeutics Inc. Opioid delivery system

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1566610B1 (de) * 1967-05-05 1970-09-03 Heyer Gmbh Carl Vorrichtung zum Einfuehren von therapeutischen Aerosolen in die Eustachische Roehre und das Mittelohr
EP1680173B1 (fr) * 2003-10-31 2011-01-12 Trudell Medical International Systeme de manipulation d'un catheter afin d'introduire une substance dans une cavite corporelle

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164740A (en) * 1991-04-24 1992-11-17 Yehuda Ivri High frequency printing mechanism
US20040000598A1 (en) * 1991-04-24 2004-01-01 Aerogen, Inc. Method and apparatus for dispensing liquids as an atomized spray
EP0937478A1 (fr) * 1998-02-19 1999-08-25 Microflow Engineering SA Appareil et système pour l'administration de medicament intracavité pendant une chirurgie assistée par vidéo ou autres interventions endoscopiques
WO2002032486A1 (fr) * 2000-10-16 2002-04-25 Fisher & Paykel Healthcare Limited Ameliorations apportees a un dispositif utilise pour humidifier des gaz dans des processus medicaux
US6546927B2 (en) * 2001-03-13 2003-04-15 Aerogen, Inc. Methods and apparatus for controlling piezoelectric vibration
US20050084523A1 (en) * 2003-02-28 2005-04-21 Delex Therapeutics Inc. Opioid delivery system
US20050012766A1 (en) * 2003-04-21 2005-01-20 Takakazu Fukano Information communicating member, liquid container having information communicating member and liquid ejecting apparatus

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2274034A1 *

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2371409A1 (fr) * 2010-03-31 2011-10-05 AeroSurgical Limited Insufflation de cavités corporelles
US10449307B2 (en) 2013-07-24 2019-10-22 Stamford Devices Limited Nebulizer vibrating aperture plate drive frequency control and monitoring
US11660404B2 (en) 2013-07-24 2023-05-30 Stamford Devices Limited Nebulizer vibrating aperture plate drive frequency control and monitoring
US9956356B2 (en) 2013-07-24 2018-05-01 Stamford Devices Limited Nebulizer vibrating aperture plate drive frequency control and monitoring
TWI643644B (zh) * 2013-07-24 2018-12-11 Stamford Devices Limited 噴霧器隙孔板驅動頻率控制及監視
US12186477B2 (en) 2013-07-24 2025-01-07 Stamford Devices Limited Nebulizer aperture plate drive frequency control and monitoring
WO2015010809A1 (fr) * 2013-07-24 2015-01-29 Stamford Devices Limited Commande et surveillance de la fréquence de l'entraînement d'une plaque d'ouverture vibrante de nébuliseur
US11065399B2 (en) 2013-07-24 2021-07-20 Stamford Devices Limited Nebulizer vibrating aperture plate drive frequency control and monitoring
CN105592935A (zh) * 2013-07-24 2016-05-18 斯坦福设备有限公司 喷雾器振动孔板驱动频率控制及监测
EP3932566A1 (fr) 2017-08-25 2022-01-05 Stamford Devices Limited Protection d'une plaque munie d'orifice durant la génération d'un aérosol
US11839891B2 (en) 2017-08-25 2023-12-12 Stamford Devices Limited Protection of aperture plate during aerosol generation
WO2019038408A1 (fr) 2017-08-25 2019-02-28 Stamford Devices Limited Protection de plaque d'orifice pendant la génération d'aérosol
WO2022263049A1 (fr) * 2021-06-16 2022-12-22 Stamford Devices Limited Système de ventilateur
WO2024039805A1 (fr) * 2022-08-18 2024-02-22 Conmed Corporation Systèmes d'humidification pour procédures chirurgicales
EP4431138A1 (fr) * 2023-03-15 2024-09-18 Feellife Health Inc. Atomiseur et dispositif d'atomisation

Also Published As

Publication number Publication date
EP2274034A1 (fr) 2011-01-19

Similar Documents

Publication Publication Date Title
US11738159B2 (en) Insufflation system
US20110178458A1 (en) Insufflation of body cavities
US20090240192A1 (en) Insufflation of body cavities
US20110230820A1 (en) Insufflation of body cavities
EP2464403B1 (fr) Système d'insufflation
US11806478B2 (en) Supplemental oxygen delivery system
US20120234321A1 (en) Aerosolisation system
EP2274034A1 (fr) Insufflation de cavités corporelles
JP2001054574A (ja) 医用ネブライザ
EP2371409A1 (fr) Insufflation de cavités corporelles
IE20100498A1 (en) An insufflation system
IE20080238A1 (en) Insufflation of body cavities
IE20090237A1 (en) Insufflation of body cavities
EP2388041A1 (fr) Appareil de distribution d'un agent dans l'abdomen
EP2457611A2 (fr) Methode et appareil permettant de delivrer un agent dans l'abdomen
IE20090749A1 (en) A supplemental oxygen delivery system
EP1809366A1 (fr) Procede et appareil d'administration d'un agent dans l'abdomen
WO2006041476A1 (fr) Procede et appareil d'administration d'un agent dans l'abdomen

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09723714

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2009723714

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE